The landscape of global surveillance and control is evolving rapidly, with governments embracing a new tool that goes beyond the conventional. As the world eagerly anticipates the COVID vaccine release, and governments enforce negative test proofs for travel, a discrete yet potent technology is emerging. Gone are the days when warnings of the "coming Microchip" were dismissed as conspiracy theories. The era of the microchip is upon us, and it's cloaked in a different narrative.
Unveiling a New Era: Biochips and Pandemics
Governments are shrewdly presenting the microchip not as a means of monitoring and controlling their populace, but as a solution to track and identify COVID and other Coronaviruses. This strategy resonates effortlessly with a public haunted by government directives and mainstream media's persistent fear-mongering over the last half-year.
Raul Diego, in his illuminating article titled "A DARPA-Funded Implantable Microchip to Detect COVID-19 Could Hit Markets By 2021," sheds light on the creation and impending release of this groundbreaking biochip.
The Biochip's Genesis: A Scientific Revelation
Back in 2010, a fortuitous accident uncovered a scientific treasure that has since shaken the foundations of modern medicine. Derek Rossi, a Canadian scientist, stumbled upon the ability to "reprogram" the molecules orchestrating cellular development in the human body and across biological entities. These molecules, termed 'messenger ribonucleic acid' or mRNA, have now assumed a role that has far-reaching implications.
Rossi's revelation rippled through the corridors of science and medicine, heralding an era of potential previously unimagined. The ability to manipulate mRNA, thereby engineering the production of diverse cell types, has transformed the landscape of Western medicine. Rossi's assertion that "you could get the mRNA to express any protein in the cells" was a watershed moment that reverberates to this day.
Pioneering the Future: Hydrogel and Beyond
As the scope of this discovery broadened, research surged forward. The Defense Advanced Research Projects Agency (DARPA), even as early as 2006, embarked on a journey to identify upper respiratory pathogens via the Predicting Health and Disease (PHD) program. The result was the emergence of the Biological Technologies Office (BTO), a powerhouse of innovation.
In 2014, DARPA's BTO initiated the "In Vivo Nanoplatforms" (IVN) program, an exploration into implantable nanotechnologies that eventually birthed 'hydrogel'. Hydrogel, a nanotechnology marvel, captured attention for its potential to be integrated into the body, transmitting light-based signals wirelessly, much like 5G technology.
Steering Biology through Technology: The Profusa Paradigm
Crucially, this technology translates to remote manipulation of biological processes. Profusa Inc., a private enterprise, emerged as the conduit for disseminating this innovation. Profusa's operations are propelled by substantial funding from the National Institutes of Health (NIH) and DARPA. In an unexpected twist, Profusa announced an injectable biochip tailored for detecting viral respiratory diseases, including COVID-19, effectively entering the tumultuous COVID-19 landscape.
Decoding the Biochip: A Glimpse into its Mechanics
Patrick Tucker, in his discerning analysis for Defense One, elucidates the intricate workings of the biochip. Comprising a 3mm hydrogel string injected under the skin, this network includes a specialized molecule. The molecule orchestrates a fluorescent signal that signifies the body's response to an infection. Coupled with an electronic component on the skin's surface, this sensor detects the fluorescent signal and generates data that can be shared with medical professionals, websites, and more. This innovation mirrors a portable blood lab on the skin, capable of identifying illness before overt symptoms manifest.
Entwining Interests: The Nexus of Corporations and Government
It's not merely the corporate world that embraces this paradigm shift; government bodies like the National Institute of Allergy and Infectious Diseases (NIAID) also display vested interest. With funding from Fauci's NIAID and the NIH, a report surfaced endorsing an mRNA Vaccine against SARS-CoV-2. This report bolstered the case for further vaccine development.
The NIH's joint stake in Moderna's mRNA COVID-19 vaccine heightened intrigue. Though Moderna contested the federal government's position on shared intellectual property, the trajectory seemed clear. All that remained was a delivery system, an obstacle Moderna was addressing independently.
The Crossroads of Humanity: A Critical Juncture
The impending reality is undeniable; the era of the microchip isn't looming—it's here. The global populace faces a pivotal decision—submit to the microchip or bear the consequences. Judging by the widespread compliance witnessed during the pandemic, the odds seem stacked against the preservation of personal freedom.
In this evolving narrative, the biochip stands as a symbol of control and a harbinger of transformation. Society now confronts an unprecedented juncture—a choice that transcends the individual and shapes the future of humanity.
We need your help to continue to post news that matters...You can support our efforts by buying us a coffee... It’s quick, secure, and easy. https://gogetfunding.com/realnewscast/